IL6 and cancer: We have confirmed that alterations in the composition of oral bacteria can contribute to a reduction in SCFAs and the expression of the FFAR 2, resulting in an inflammatory response through the upregulation of TNFAIP8 and the IL-6/STAT3 pathway, ultimately increasing the risk of cancer onset.